Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Mosquirix Co-administered with Childhood Vaccines
NCT02699099Phase 3Completed
- Sponsor
- GSK
- Start
- May 2017
- Primary completion
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of RTS,S in Plasmodium falciparum malaria, sponsored by GSK. Started May 2017; status: completed.
02
Drugs
RTS,S
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02699099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02699099.